Foreseeing liquidity

Foresite marks first liquidity event for its late-stage life science portfolio

Foreseeing liquidity

Foresite Capital has made five investments since its launch last summer, one of which became liquid about a week ago using the Form 10 pathway, the firm's founder and CEO, Jim Tananbaum, told BioCentury.

The firm employs a mix

Read the full 391 word article

How to gain access

Continue reading with a
two-week free trial.